Prognostic Impacts of β-Blockers in Acute Coronary Syndrome Patients without Heart Failure Treated by Percutaneous Coronary Intervention.
Sign Up to like & getrecommendations! Published in 2021 at "Pharmacological research"
DOI: 10.1016/j.phrs.2021.105614
Abstract: BACKGROUND The use of β-blockers for acute coronary syndrome (ACS) patients without heart failure (HF) is controversial, and lacks of evidence in the era of reperfusion and intensive secondary preventions. This study aimed to investigate… read more here.
Keywords: analysis; impacts blockers; acute coronary; prognostic impacts ... See more keywords